53297-69-1Relevant articles and documents
NLRP MODULATORS
-
Page/Page column 346; 356, (2020/01/31)
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein, useful to treat connected to the modulation of NRLP3.
Non-nucleoside reverse transcriptase inhibitors
-
Page/Page column 16, (2010/11/26)
The present invention provides for compounds useful for treating an HIV-1 infection, or preventing an HIV-1 infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein R1-R4 and Ar are as herein defined. Also disclosed in t